Stock Events

Stock Events

Island Pharmaceuticals Limited 

€0.2
3
-€0.01-4.72% Thursday 06:06

Statistics

Day High
0.2
Day Low
0.2
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
54.35M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25FebExpected
Q2 2025
Q4 2025
-0.01
-0.01
-0.01
-0
Expected EPS
-0.002936892868
Actual EPS
-0.010730954709999999

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-4.44MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 7X0.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. focuses on the development and marketing of drugs in areas similar to those pursued by Island Pharmaceuticals, including antiviral drugs, which makes them a direct competitor.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that develops vaccines and therapeutic drugs that could compete with Island Pharmaceuticals' antiviral drug development.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including medicines and vaccines for infectious diseases, directly competing with Island Pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson engages in the research and development of pharmaceuticals for infectious diseases, competing in the same space as Island Pharmaceuticals.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. researches and develops pharmaceutical products, including those for viral infections, positioning them as a competitor to Island Pharmaceuticals.
Novartis
NVS
Mkt Cap237.61B
Novartis AG focuses on patented medicines for a range of diseases, including viral infections, which pits them against Island Pharmaceuticals in the pharmaceutical market.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC develops therapies for various infectious diseases, competing with Island Pharmaceuticals in the area of drug development for similar ailments.
Sanofi
SNY
Mkt Cap124.45B
Sanofi operates globally, focusing on pharmaceuticals including vaccines and therapies for infectious diseases, making them a competitor to Island Pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb Company offers prescription pharmaceuticals in several therapeutic areas, including virology, which aligns them as competitors with Island Pharmaceuticals.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc specializes in the creation and marketing of vaccines and medications for infectious diseases, directly competing with Island Pharmaceuticals in this niche.

About

Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for antiviral therapeutics in Australia and the United States of America. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. Island Pharmaceuticals Limited was founded in 2017 and is based in Camberwell, Australia.
Show more...
CEO
ISIN
AU0000138869
WKN
000A2QSJR

Listings

F
DE
7X0.F
OTC Link
US
ILPLF
AU
AU
ILA.AU

0 Comments

Share your thoughts

FAQ

What is Island Pharmaceuticals Limited stock price today?▼
The current price of 7X0.F is €0.2 EUR — it has decreased by -4.72% in the past 24 hours. Watch Island Pharmaceuticals Limited stock price performance more closely on the chart.
What is Island Pharmaceuticals Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Island Pharmaceuticals Limited stocks are traded under the ticker 7X0.F.
What is Island Pharmaceuticals Limited market cap?▼
Today Island Pharmaceuticals Limited has the market capitalization of 54.35M
When is the next Island Pharmaceuticals Limited earnings date?▼
Island Pharmaceuticals Limited is going to release the next earnings report on August 27, 2026.
What were Island Pharmaceuticals Limited earnings last quarter?▼
7X0.F earnings for the last quarter are -0.01 EUR per share, whereas the estimation was -0 EUR resulting in a -265.38% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Island Pharmaceuticals Limited revenue for the last year?▼
Island Pharmaceuticals Limited revenue for the last year amounts to 0 EUR.
What is Island Pharmaceuticals Limited net income for the last year?▼
7X0.F net income for the last year is -4.44M EUR.
When did Island Pharmaceuticals Limited complete a stock split?▼
Island Pharmaceuticals Limited has not had any recent stock splits.